Decision Diagnostics Corp. (DECN)
-OTC BB 0.22 
0.01(4.35%) May 17, 2:34PM EDT
| Prev Close: | 0.23 |
|---|
| Open: | 0.22 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.65 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.22 - 0.22 |
|---|
| 52wk Range: | 0.05 - 0.40 |
|---|
| Volume: | 15,814 |
|---|
| Avg Vol (3m): | 79,092 |
|---|
| Market Cap: | 3.17M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- DECISION DIAGNOSTICS CORP Files SEC form 8-K/A, Changes in Registrant's Certifying AccountantEDGAR Online(Wed, May 1)
- DECISION DIAGNOSTICS CORP FinancialsEDGAR Online Financials(Sat, Apr 20)
- DECISION DIAGNOSTICS CORP Files SEC form 8-K, Changes in Registrant's Certifying AccountantEDGAR Online(Tue, Apr 16)
- Decision Diagnostics Corp. and Its Subsidary PharmaTech Solutions Seek to End Pharma Giant's Alleged Restraint of Trade TacticsMarketwired(Fri, Apr 5)
- Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust ViolationsMarketwired(Thu, Apr 4)
- J&J Faces Potentially Disrupting Competition In Its Lucrative Glucose Monitoring Business From Tiny Diagnostics Outfitat Forbes(Mon, Mar 11)
- Opportunity and Market for Decision Diagnostics (OTCBB: DECN) Shasta GenStrip(R), at Home Diagnostic for Testing Blood GlucoseMarketwired(Tue, Dec 4)
- Q&A With Medical Technology Stock Decision Diagnostics (OTCBB: DECN)Marketwired(Wed, Nov 28)
- DECISION DIAGNOSTICS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Nov 19)
- DECISION DIAGNOSTICS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Aug 20)
- DECISION DIAGNOSTICS CORP FinancialsEDGAR Online Financials(Thu, May 24)
- DECISION DIAGNOSTICS CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 15)
- DECISION DIAGNOSTICS CORP Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 16)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 0.53 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Decision Diagnostics Corp. engages in the distribution of prescription and non-prescription diagnostics and home testing products in the United States.
View More